Keyphrases
IgA Nephropathy (IgAN)
100%
Spleen Tyrosine Kinase
100%
Tubular Inflammation
100%
Tyrosine Kinase Inhibition
100%
Human Mesangial Cells
71%
Healthy Controls
42%
Renal Tubular Epithelial Cells
42%
NF-B
28%
Tubular Injury
28%
Cell-conditioned Medium
28%
R406
28%
Signal Transduction
14%
Inflammation
14%
Interleukin-6
14%
Potential Therapeutics
14%
Renal Tubule
14%
Interleukin-8
14%
Cell Proliferation
14%
Inflammatory Response
14%
Control Subjects
14%
Cytokine Production
14%
Immune Response
14%
Inflammatory Cells
14%
Intercellular Adhesion molecule-1 (ICAM-1)
14%
Receptor Tyrosine Kinase
14%
Conditioned Medium
14%
Biopsy-proven
14%
MAPK Signaling
14%
Biopsy Specimen
14%
Tubular Cells
14%
Pathogenic Role
14%
Phosphorylated p65
14%
Human Kidney Biopsy
14%
Spleen Tyrosine Kinase Inhibitor
14%
Polymeric IgA
14%
Medicine and Dentistry
Immunoglobulin A Nephropathy
100%
Janus Kinase 1
100%
Protein Kinase Syk
100%
Mesangial Cell
71%
Immunoglobulin A
57%
Epithelial Cell
42%
Fostamatinib
28%
In Vitro
14%
extracellular signal regulated kinase
14%
Cytokine Production
14%
Tumor Necrosis Factor
14%
Interleukin 6
14%
Serositis
14%
Cell Proliferation
14%
Biopsy Technique
14%
Intercellular Adhesion Molecule 1
14%
Immune Response
14%
Signal Transduction
14%
Renal Biopsy
14%
Inflammatory Cell
14%
MAPK Signaling
14%
Protein Tyrosine Kinase
14%
Renal Tubule
14%
Protein Kinase Syk Inhibitor
14%
Pharmacology, Toxicology and Pharmaceutical Science
Inflammation
100%
Immunoglobulin A Nephropathy
100%
Janus Kinase 1
100%
Protein Kinase Syk
100%
Immunoglobulin A
57%
Fostamatinib
28%
Cytokine
14%
Interleukin 6
14%
Tumor Necrosis Factor
14%
Intercellular Adhesion Molecule 1
14%
Protein Tyrosine Kinase
14%
Protein Kinase Syk Inhibitor
14%
Biochemistry, Genetics and Molecular Biology
Janus Kinase 1
100%
Immunoglobulin A
100%
Mesangial Cell
50%
Fostamatinib
20%
Signal Transduction
10%
Cell Proliferation
10%
extracellular signal regulated kinase
10%
Tumor Necrosis Factor
10%
Cytokine Production
10%
Immune Response
10%
Interleukin 8
10%
Interleukin 6
10%
MAPK Signaling
10%
Tyrosine Kinase Inhibitor
10%
ICAM-1
10%
Non-Receptor Tyrosine Kinase
10%